Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.18B | 26.18B | 26.64B | 24.13B | 22.24B | 12.94B |
Gross Profit | 14.39B | 14.39B | 15.04B | 13.91B | 11.65B | 5.23B |
EBITDA | 1.59B | 1.54B | 1.93B | 1.65B | 1.06B | -6.32B |
Net Income | 314.06M | 314.02M | 619.81M | 168.09M | 477.68M | -5.42B |
Balance Sheet | ||||||
Total Assets | 21.33B | 21.33B | 23.20B | 22.99B | 24.58B | 26.14B |
Cash, Cash Equivalents and Short-Term Investments | 4.57B | 4.57B | 5.16B | 5.41B | 6.12B | 6.72B |
Total Debt | 8.17B | 8.17B | 9.17B | 9.73B | 10.74B | 11.04B |
Total Liabilities | 15.06B | 15.06B | 16.96B | 17.12B | 18.66B | 20.58B |
Stockholders Equity | 6.27B | 6.27B | 6.24B | 5.87B | 5.93B | 5.57B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 385.33M | 692.34M | 729.38M | -509.50M | -4.92B |
Operating Cash Flow | 0.00 | 926.34M | 1.22B | 1.10B | -247.82M | -4.49B |
Investing Cash Flow | 0.00 | -198.47M | -591.36M | -502.14M | 132.52M | -400.64M |
Financing Cash Flow | 0.00 | -1.31B | -915.08M | -1.32B | -486.78M | 7.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | 12.41B | 4.30 | 19.56% | 4.68% | 0.81% | 61.06% | |
73 Outperform | 23.27B | 19.95 | 16.10% | 3.03% | -1.02% | -32.57% | |
73 Outperform | 8.32B | 9.22 | 9.90% | ― | 11.07% | 5.85% | |
72 Outperform | 3.82B | 8.72 | 0.00% | 1.18% | 6.57% | 52.89% | |
67 Neutral | 33.68B | 5.16 | 15.97% | 1.70% | 16.16% | 13.88% | |
60 Neutral | ¥3.11B | 24.54 | ― | -3.96% | -73.55% | ||
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
ESCRIT Inc. reported a decline in its consolidated financial results for the three months ended June 30, 2025, with net sales decreasing by 11.1% compared to the previous year. The company experienced operating and ordinary losses, reflecting ongoing challenges in its market environment. Despite these setbacks, ESCRIT Inc. maintains its financial results forecast for the fiscal year ending March 31, 2026, indicating a cautious optimism about future performance.
The most recent analyst rating on (JP:2196) stock is a Hold with a Yen227.00 price target. To see the full list of analyst forecasts on ESCRIT Inc. stock, see the JP:2196 Stock Forecast page.